Solenis completes Diversey buy
Solenis has completed the previously announced acquisition of Diversey in an all-cash deal that gives Diversey an enterprise value of about $4.6 billion. The combined firm will have 71 manufacturing facilities, more than 15,000 employees and operations in over 130 countries. It will be majority-owned by Platinum Equity, with Bain Capital, which owned Diversey, keeping a minority stake.
CEO John Panichella said that this “makes Solenis a more diversified company with significantly increased scale, broader global reach and the ability to offer a ‘one-stop shop’ suite of solutions that meet customer demand and address water management, cleaning and hygiene issues on a global basis”. Considerable cross-selling opportunities are expected.
RELATED ARTICLES
Travertine Technologies and precious metal refiner Sabin Metal have announced plans have revealed plans to build a demonstration plant at Sabin’s main facility near Rochester, New York.
Two CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.
OCSiAl has opened its first European graphene nanotubes facility in Serbia. It will produce 60 tonnes/year under the Tuball band and the company plans to double this by launching a second synthesis unit within the next year. The modular design means it is able to scale production rapidly.
A pilot enforcement project carried out by national enforcement authorities in 13 European Economic Area (EEA) countries between November 2023 and April 2024 found that 6% of about 4,500 cosmetic products inspected contained hazardous substances.
Biosynth, which supplies critical raw materials and services for diagnostics, vaccines and pharmaceuticals, has officially opened its Biosynth Biological Technology site at Lifebay, a technology park in Suzhou, China.
Spanish energy and chemicals company Cepsa has renamed itself Moeve.
